CNVS CFO Reports 70,809 RSU Grant and 119,168‑Share Sale
Rhea-AI Filing Summary
Mark W. Lindsey, Chief Financial Officer of Cineverse Corp. (CNVS) reported changes in his holdings on 10/08/2025. The filing shows a disposition of 119,168 shares of Class A common stock, leaving him with several categories of equity awards: outstanding stock appreciation rights exercisable at $11.95 covering 20,000 underlying shares, and multiple restricted stock units (RSUs) and a separate RSU grant that together total 209,175 underlying Class A shares across different vesting schedules. One RSU tranche of 70,809 shares was reported as acquired on 10/08/2025 at $0 (i.e., newly granted).
The disclosure itemizes vesting timelines: portions of RSUs vest in 2026, 2027, and 2028, and SAR vesting dates include 11/14/2023 through 11/14/2025. The mix of a cashless/zero-price grant and multi-year vesting schedules indicates continued equity compensation tied to future service.
Positive
- Retention‑focused compensation with RSUs vesting across 2026–2028
- SARs provide upside alignment with a $11.95 exercise price on 20,000 underlying shares
- New RSU grant of 70,809 shares links CFO pay to future performance and tenure
Negative
- Immediate disposition of 119,168 Class A shares reduces direct insider ownership
- Potential near‑term dilution from cumulative RSUs totaling over 200,000 shares as they vest
Insights
TL;DR: CFO sold a block of shares while retaining multi‑year vested awards.
The reported disposition of 119,168 Class A shares reduces direct share holdings but the CFO still holds long‑dated equity via RSUs totaling over 200,000 shares and 20,000 SARs exercisable at $11.95. These awards vest across 2026–2028, keeping executive economic exposure linked to future company performance.
Key dependencies include future vesting and stock price performance relative to the SAR strike. Monitor scheduled vesting dates in 2026–2028 for potential future dilution or sales.
TL;DR: Equity grants combine immediate zero‑price RSUs and time‑based SARs to retain incentives.
The mix of a zero‑price RSU grant of 70,809 shares and previously awarded RSUs with staggered vesting spreads compensation over multiple years, aligning pay with retention. The SARs with a $11.95 strike on 20,000 shares add upside exposure if the share price rises above that level.
Risks include potential dilution when RSUs vest and exercise of SARs; watch vesting milestones on 04/25/2026, 09/23/2026, and 10/08/2026.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit | 70,809 | $0.00 | -- |
| holding | Stock Appreciation Right (Right to buy) | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (1)
- Includes 66,667 shares of restricted stock that vest as follows: 33,333 vest on April 25, 2026 and 33,334 vest on April 25, 2027. Of such stock appreciation rights, 6,667 vest on November 14, 2023, 6,667 vest on November 14, 2024, and 6,666 vest on November 14, 2025. Each restricted stock unit has a value equal to one share of Class A common stock. Of such RSUs, 33,333 vest on April 25 of 2026 and 33,334 vest on April 25, 2027. Each restricted stock unit has a value equal to one share of Class A common stock. Of such RSUs, 23,900 vest on September 23 of each of 2026 and 2027 and 23,899 vest on September 23, 2028. Each restricted stock unit has a value equal to one share of Class A common stock. Of such RSUs, 23,603 vest on October 8 of each of 2026, 2027 and 2028.
